Risk Stratification for Advanced Colorectal Neoplasia According to Fecal Hemoglobin Concentration in a Colorectal Cancer Screening Program

被引:90
|
作者
Auge, Josep M. [1 ]
Pellise, Maria [2 ]
Escudero, Jose M. [1 ]
Hernandez, Cristina [3 ]
Andreu, Montserrat [4 ]
Grau, Jaume [5 ]
Buron, Andrea [3 ]
Lopez-Ceron, Maria [2 ]
Bessa, Xavier [4 ]
Serradesanferm, Anna [5 ]
Piraces, Merce [3 ]
Macia, Francesc [3 ]
Guayta, Rafael [6 ]
Filella, Xavier [1 ]
Molina, Rafael [1 ]
Jimenez, Wladimiro [1 ]
Castells, Antoni [2 ]
机构
[1] Hosp Clin Barcelona, Biochem & Mol Genet Dept, E-08036 Barcelona, Spain
[2] Univ Barcelona, Dept Gastroenterol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer,Ctr Invest, Barcelona, Spain
[3] Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain
[4] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain
[5] Univ Barcelona, Hosp Clin, Prevent Med & Hosp Epidemiol Dept, Barcelona, Spain
[6] Council Coll Pharmacists Catalonia, Barcelona, Spain
关键词
Colorectal Cancer Screening; Fecal Immunochemical Tests; Colonoscopy; Risk Stratification; OCCULT BLOOD-TEST; IMMUNOCHEMICAL TEST; AVERAGE RISK; TESTS; COLONOSCOPY; POPULATION; PERFORMANCE; PREDICTION; SIGMOIDOSCOPY; SURVEILLANCE;
D O I
10.1053/j.gastro.2014.06.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The latest generation of fecal immunochemical tests (FIT) allows for quantitation of hemoglobin in feces, allowing for selection of optimal cut-off concentrations. We investigated whether individuals with positive results from quantitative FITs, in combination with other factors, could be identified as being at greatest risk for advanced colorectal neoplasia. METHODS: In a retrospective study, we analyzed data from a consecutive series of 3109 participants with positive results from FITs (>= 20 mu g/g of feces) included in the first round of the Barcelona colorectal cancer screening program, from December 2009 through February 2012. All participants underwent colonoscopy and were assigned to groups with any advanced colorectal neoplasia or with nonadvanced colorectal neoplasia (but with another diagnosis or normal examination findings). RESULTS: Median fecal hemoglobin concentrations were significantly higher in participants with advanced colorectal neoplasia (105 mu g/g; interquartile range, 38-288 mu g/g) compared with participants with nonadvanced colorectal neoplasia (47 mu g/g; interquartile range, 23-119 mu g/g) (P < .001). Positive predictive values for advanced colorectal neoplasia, determined using arbitrary fecal hemoglobin concentrations, differed with sex and age. Multivariate logistic regression analysis identified sex (men: odds ratio [OR], 2.07; 95% confidence interval, 1.78-2.41), age (60-69 y: OR, 1.24; 95% confidence interval, 1.07-1.44), and fecal hemoglobin concentration (>177 mu g/g: OR, 3.80; 95% confidence interval, 3.07-4.71) as independent predictive factors for advanced colorectal neoplasia. Combining these factors, we identified 16 risk categories associated with different probabilities of identifying advanced colorectal neoplasia. Risk for advanced colorectal neoplasia increased 11.46-fold among individuals in the highest category compared with the lowest category; positive predictive values ranged from 21.3% to 75.6%. CONCLUSIONS: Fecal hemoglobin concentration, in addition to sex and age, in individuals with positive results from FITs can be used to stratify probability for the detection of advanced colorectal neoplasia. These factors should be used to prioritize individuals for colonoscopy examination.
引用
收藏
页码:628 / +
页数:10
相关论文
共 50 条
  • [41] FECAL MICROBIOTA DIFFERENCES ACCORDING TO THE RISK OF ADVANCED COLORECTAL NEOPLASMS
    Yang, Hyo-Joon
    Kwon, Min-Jung
    Chang, Yoosoo
    Song, Seul-Ki
    Ahn, Kwang-Sung
    Kim, Han-Na
    Yun, Yeojun
    Kim, Hyung-Lae
    Park, Dongil
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S631 - S631
  • [42] Precision Colorectal Cancer Fecal Immunological Test Screening With Fecal-Hemoglobin-Concentration-Guided Interscreening Intervals
    Yen, Amy Ming-Fang
    Hsu, Chen-Yang
    Lin, Ting-Yu
    Su, Chiu-Wen
    Chiu, Han-Mo
    Chen, Tony Hsiu-Hsi
    Chen, Sam Li-Sheng
    [J]. JAMA ONCOLOGY, 2024, 10 (06) : 765 - 772
  • [43] Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening
    Gies, Anton
    Cuk, Katarina
    Schrotz-King, Petra
    Brenner, Hermann
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (08) : 1223 - 1231
  • [44] Equal Advanced Neoplasia Detection Rates in First and Second Round of an Fecal Immunochemical Test Based Colorectal Cancer Screening Program
    Denters, Maaike
    Deutekom, Marije
    Bossuyt, Patrick M.
    Fockens, Paul
    Dekker, Evelien
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S186 - S186
  • [45] Your disease risk (YDR) and risk stratification for advanced colorectal neoplasia (Acn)
    Schroy, Paul C.
    Ahn, Lynne B.
    Glick, Julie
    Robinson, Patricia
    Lydotes, Maria
    Mylvaganam, Shamini
    Ashba, Jacqueline
    Atkinson, Michael
    Colditz, Graham A.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A185 - A185
  • [46] Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up
    Carballal, Sabela
    Sanchez, Ariadna
    Moreira, Leticia
    Eduardo Cuellar-Monterrubio, Jesus
    Bernuy, Julio
    Daca, Maria
    Ortiz, Oswaldo
    Ocana, Teresa
    Rivero-Sanchez, Liseth
    Jung, Gerhard
    Serradesanferm, Anna
    Pozo, Angels
    Grau, Jaume
    Tora, Isabel
    Zaffalon, Diana
    Castells, Antoni
    Pellise, Maria
    Balaguer, Francesc
    [J]. ENDOSCOPY, 2022, 54 (07) : 688 - 697
  • [47] Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program
    Koivogui, Akoi
    Le Mab, Guillaume
    Benamouzig, Robert
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (12): : 1891 - 1899
  • [48] Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD: Accurate or Not? Reply
    Wong, Germaine
    Hope, Richard L.
    Howard, Kirsten
    Chapman, Jeremy R.
    Castells, Antoni
    Roger, Simon D.
    Bourke, Michael J.
    Macaskill, Petra
    Turner, Robin
    Williams, Gabrielle
    Lim, Wai H.
    Lok, Charmaine E.
    Diekman, Fritz
    Cross, Nicholas
    Sen, Shaundeep
    Allen, Richard D. M.
    Chadban, Steven J.
    Pollock, Carol A.
    Tong, Allison
    Teixeira-Pinto, Armando
    Yang, Jean Y. H.
    Williams, Narelle
    Au, Eric
    Kieu, Anh
    James, Laura
    Craig, Jonathan C.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (11): : 2276 - 2277
  • [49] A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
    Niedermaier, Tobias
    Alwers, Elizabeth
    Chen, Xuechen
    Heisser, Thomas
    Hoffmeister, Michael
    Brenner, Hermann
    [J]. CANCER COMMUNICATIONS, 2023, 43 (08) : 947 - 950
  • [50] Development and Validation of a Risk Stratification-based Screening Model for Predicting Colorectal Advanced Neoplasia in Korea
    Kim, Dong Hyun
    Cha, Jae Myung
    Shin, Hyun Phil
    Joo, Kwang Ro
    Lee, Joung Il
    Park, Dong Il
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (01) : 41 - 49